MACOM Technology Solutions Holdings, Inc. has disclosed a significant transaction involving the sale of shares by one of its top executives. Stephen Daly, a director and officer at the company, sold 59,939 shares of common stock on November 11, 2026. The total value of this sale is approximately $13.6 million, as reported in a recent SEC filing.
This event is particularly noteworthy as it showcases ongoing management activity within the semiconductor industry, where MACOM operates. The sale demonstrates confidence from leadership in the company's strategic direction and future performance.
Background
MACOM Technology Solutions Holdings, Inc. is a prominent player in the semiconductor sector, classified under the SIC code 3674, which encompasses semiconductors and related devices. The company trades on the Nasdaq under the ticker symbol MTSI. As a large accelerated filer, MACOM has been active in the market, with recent filings indicating a robust operational status.
What the Filing Says
The SEC filing, dated November 12, 2026, outlines the details of the stock sale. It notes, “Sales that were executed on November 11, 2026 are being reported on this Form 144 filed on November 12, 2026 given the EDGAR system was not accepting filings on November 11, 2026 in observance of the federal holiday.” This provides context for the timing of the filing and the transaction.
Impact
This transaction may affect various stakeholders, including investors and market analysts, who closely monitor executive actions as indicators of company health and market sentiment. The sale of shares by a high-ranking official like Daly can influence investor perceptions and market dynamics within the semiconductor industry.
What's Next
The filing does not say what happens next.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










